Yang KH

Department of Psychiatry, University of California San Diego School of Medicine, La Jolla, USA.

11 papers · ORCID

ArticlePsilocybin

Psilocybin use, mental health treatment utilization, and unmet treatment need among US individuals with depression.

Eun AC, Yang KH, Palamar JJ

Europe PMC2026
ArticlePsychedelics

The Case for More Aggressive Masking in Psychedelic Trials.

Yang KH, Heifets BD, Krystal A +1

Europe PMC2026
ArticlePsilocybin

Association Between Lifetime Hallucinogen Use and Valvular Heart Disease: Findings from the All of Us Research Program.

Yang KH, Rasmussen M, Bhatt K +4

Europe PMC2026
ArticlePsilocybin

Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among U.S. Adults.

Yang KH, Satybaldiyeva N, Kepner W +3

Europe PMC2026
ArticlePsilocybin

Prevalence and Correlates of Past-Year Psilocybin Use in the United States.

Yang KH, Eun A, Palamar JJ

Europe PMC2026
ArticlePsychedelics

Substance Use Patterns Across the Sexual Identity Spectrum Among U.S. Individuals.

Yang KH, Mueller LA, Han BH +1

Europe PMC2026
ArticleMDMA

Prevalence and Correlates of Lifetime Ecstasy/MDMA Use Among Asian American and Pacific Islander Adult Populations in the United States, 2015-2020.

Kepner W, Yang KH, Dionicio P +5

Europe PMC2026
ArticleKetamine

Trends and characteristics in ketamine use among US adults with and without depression, 2015-2022.

Yang KH, Kepner W, Cleland CM +1

Europe PMC2025
ArticleMDMA

Prevalence and Correlates of Past Year Ecstasy/MDMA Use in the United States.

Yang KH, Kepner W, Nijum A +2

Europe PMC2023
ArticlePsilocybin

Microdosing psilocybin for chronic pain: a case series.

Lyes M, Yang KH, Castellanos J +1

Europe PMC2023
ArticleMDMA

Past-year hallucinogen use in relation to psychological distress, depression, and suicidality among US adults.

Yang KH, Han BH, Palamar JJ

Europe PMC2022